|Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms|
TR De Kievit, MD Parkins, RJ Gillis, R Srikumar, H Ceri, K Poole, ...
Antimicrobial agents and chemotherapy 45 (6), 1761-1770, 2001
|A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients|
CD Sibley, MD Parkins, HR Rabin, K Duan, JC Norgaard, MG Surette
Proceedings of the National Academy of Sciences 105 (39), 15070-15075, 2008
|Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation|
MD Parkins, H Ceri, DG Storey
Molecular microbiology 40 (5), 1215-1226, 2001
|Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections|
CD Sibley, K Duan, C Fischer, MD Parkins, DG Storey, HR Rabin, ...
PLoS Pathog 4 (10), e1000184, 2008
|Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections|
MD Parkins, DM Sabuda, S Elsayed, KB Laupland
Journal of antimicrobial chemotherapy 60 (3), 613-618, 2007
|Culture enriched molecular profiling of the cystic fibrosis airway microbiome|
CD Sibley, ME Grinwis, TR Field, CS Eshaghurshan, MM Faria, SE Dowd, ...
PloS one 6 (7), e22702, 2011
|Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient|
ML Workentine, CD Sibley, B Glezerson, S Purighalla, JC Norgaard-Gron, ...
PloS one 8 (4), e60225, 2013
|Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis|
MD Parkins, RA Floto
Journal of Cystic Fibrosis 14 (3), 293-304, 2015
|Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐Resistant Pseudomonas aeruginosa in the Calgary Health Region: Importance of …|
KB Laupland, MD Parkins, DL Church, DB Gregson, TJ Louie, JM Conly, ...
Journal of Infectious Diseases 192 (9), 1606-1612, 2005
|Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study|
EO Billington, SH Phang, DB Gregson, JDD Pitout, T Ross, DL Church, ...
International Journal of Infectious Diseases 26, 76-82, 2014
|Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection|
MD Parkins, DB Gregson, JDD Pitout, T Ross, KB Laupland
Infection 38 (1), 25-32, 2010
|The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature review|
MD Parkins, CD Sibley, MG Surette, HR Rabin
Pediatric pulmonology 43 (5), 490-497, 2008
|Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis|
MD Parkins, R Somayaji, VJ Waters
Clinical microbiology reviews 31 (4), 2018
|Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa|
MD Parkins, JC Rendall, JS Elborn
Chest 141 (2), 485-493, 2012
|The genus Prevotella in cystic fibrosis airways|
TR Field, CD Sibley, MD Parkins, HR Rabin, MG Surette
Anaerobe 16 (4), 337-344, 2010
|The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.|
CD Sibley, MD Parkins, HR Rabin, MG Surette
Current opinion in investigational drugs (London, England: 2000) 10 (8), 787-794, 2009
|Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population|
MD Parkins, VM Parkins, JC Rendall, S Elborn
Therapeutic advances in respiratory disease 5 (2), 105-119, 2011
|Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections|
JT Ngo, MD Parkins, DB Gregson, JDD Pitout, T Ross, DL Church, ...
Infection 41 (1), 41-48, 2013
|Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF)|
Y Maeda, JS Elborn, MD Parkins, J Reihill, CE Goldsmith, WA Coulter, ...
Journal of Cystic Fibrosis 10 (2), 133-139, 2011
|McKay agar enables routine quantification of the ‘Streptococcus milleri’group in cystic fibrosis patients|
CD Sibley, ME Grinwis, TR Field, MD Parkins, JC Norgaard, DB Gregson, ...
Journal of medical microbiology 59 (5), 534-540, 2010